Core Insights - Treatment.com AI Inc. has successfully completed the acquisition of Rocket Doctor, enhancing its mission to integrate AI with virtual healthcare delivery [2][9] - The acquisition has led to significant growth in patient volume and physician adoption for Rocket Doctor, indicating strong market demand [3][9] Company Achievements - Rocket Doctor reported a 112% year-over-year increase in patient volume in Alberta, with 36,779 patients seen in the past year [3][9] - The platform has served over 71,000 Albertans, with 35% of patients from communities with populations under 25,000, highlighting its role in underserved areas [3] - Physician adoption increased by 218%, from 22 active physicians last year to 70 this year, allowing for rapid scaling [3] Product Development - Treatment.com AI launched a new generation of the Medical Education Suite (MES) at the University of Minnesota Medical School, featuring AI-simulated patients for assessing third-year medical students [4] - The MES has the potential to reduce exam administration costs by approximately 40% and decrease faculty workload [4] Partnerships and Collaborations - Rocket Doctor initiated a virtual care program in California with Central California Alliance for Health, serving around 450,000 members [5] - In Canada, Rocket Doctor partnered with Melanoma Canada to enhance follow-up care for high-risk skin cancer patients in Ontario, Alberta, and British Columbia [6] Recognition and Awards - Rocket Doctor was named Top Clinical Innovator by the American Telemedicine Association at the NEXUS2025 conference, recognizing its physician-led virtual care model [7][9] - The company has been invited to participate in prestigious accelerators and thought leadership programs, including the UC Berkeley Health Engine Accelerator and AARP's AgeTech Accelerator [8][9] Leadership and Insights - Dr. William Cherniak, CEO of Rocket Doctor, emphasized the transformational period for both companies, focusing on a shared vision and execution across various healthcare fronts [12] - A peer-reviewed research paper co-authored by Dr. Cherniak and other physicians provides insights into patient behavior and the role of digital tools in enhancing health equity [11]

本文来自微信公众号：医学界，作者：燕小六，责编：汪航，题图来自：AI生成 连日来，全国多所高校陆续发布2025年招生章程，其中一项颇受关注的变化是：多所中医药高校调整专业选科要求，允许历史类毕业生报考。 这意味着，文科生在本科阶段也能学医了。但截至目前，这一变化主要发生在中医领域，多数临床医学等西医本科专业，依然强调物理、化 学、生物等理科知识背景。 对于这一变化，有人认为：不管是传统医学还是现代医学，仍应该强调化学、生物等理科知识；也有人表示调整合理、本该如此。 化学不再是学医"必考项"？ 综合过往各校招生信息，学医必选物理加化学，这是一条多年来的要求。而如今，不少高校的中医学类专业与"物化"解绑。 6月9日，重庆中医药学院发布2025年普通高等教育招生章程，2025年招生专业包括中医学、中西医临床医学、针灸推拿学等12个，比去年增加 一个专业"中草药栽培与鉴定"。 其中，5年制的中医学、针灸推拿学、中医骨伤科学、中医养生学和中医康复学等5个专业，在选科方面有显著变化。"医学界"检索发现，2024 年相关专业的选科限定为"物理+化学"。而根据2025年招生章程，其选科要求调整为"物理+不限""历史+不限"。 ...

Core Insights - Treatment.com AI Inc. has launched its latest Medical Education Suite (MES), an AI-powered platform for clinical skills assessment, successfully deployed at the University of Minnesota Medical School [1][5] - The MES aims to enhance the delivery and evaluation of Objective Structured Clinical Examinations (OSCEs) by providing scalable, rigorous, and cost-effective solutions [1][5] Group 1: Deployment and Implementation - The MES was deployed with over 240 third-year medical students, marking the first large-scale implementation of computer-simulated patient cases developed through the Global Library of Medicine (GLM) [2][5] - The deployment demonstrated complete technical reliability and seamless integration into the existing OSCE workflow at the University of Minnesota [2][6] Group 2: Features and Benefits - The MES incorporates AI-simulated patients and real-time scoring, which supports faster, accurate, and objective assessments, potentially leading to approximately 40% cost savings for the University of Minnesota [5][6] - The platform is designed to reduce faculty preparation and administrative workload while providing objective evaluations aligned with clinical learning objectives [6][8] Group 3: Educational Impact - Early feedback indicates that the MES enhances the student learning experience and strengthens the reliability of OSCE results, helping students build stronger clinical skills [4][6] - The platform combines AI-simulated patients with automated feedback, allowing faculty to assess various competencies such as diagnostic reasoning and clinical prioritization [4][6] Group 4: Future Prospects - Treatment.com AI is engaging with various medical schools to extend the MES offering across North America, the UK, and other international OSCE markets [8] - Preliminary results of the MES's accuracy and precision were presented at the AAMC's 2025 Group on Information Resources meeting, with further scientific publications planned [7]

Core Insights - Treatment.com AI Inc. has launched its latest Medical Education Suite (MES), an AI-powered platform aimed at enhancing clinical skills assessment in medical education [1][7] - The University of Minnesota Medical School has successfully deployed the MES with over 240 third-year medical students, marking a significant step in the integration of AI in medical training [2][4] Company Overview - Treatment.com AI utilizes artificial intelligence and clinical expertise to address inefficiencies in the healthcare sector, developing the Global Library of Medicine (GLM) to support healthcare professionals [9] - The MES is designed to provide scalable, rigorous, and cost-effective Objective Structured Clinical Examinations (OSCEs), improving the educational experience for medical students [1][3] Deployment and Features - The MES was implemented seamlessly into the University of Minnesota's existing OSCE workflow, demonstrating complete technical reliability during deployment [2][4] - Key features of the MES include AI-simulated patients, real-time scoring, and automated feedback, which enhance the objectivity and consistency of student evaluations [4][8] Cost Efficiency - The University of Minnesota reported approximately 40% cost savings in administrative expenses due to the implementation of the MES [8][7] - The platform aims to reduce faculty preparation and administrative workload while aligning evaluations with clinical learning objectives [8][4] Future Prospects - Treatment.com AI is actively engaging with various educational institutions to expand the MES offering across North America, the UK, and other international markets [6][7] - Preliminary results regarding the accuracy and precision of the GLM as applied in the MES were presented at the AAMC's 2025 Group on Information Resources meeting, with further scientific publications in preparation [5][7]